Bharat Biotech in tie-up with the US-based company FluGen and University of Wisconsin Madison to develop a vaccine named “Coro-Flu” to fight against COVID-19. CoroFlu will build on the backbone of FluGen’s flu vaccine candidate known as M2SR.
Click Here To Get Test Series For SBI PO 2020
The vaccine is being developed on the basis of FluGen’s flu vaccine candidate known as M2SR, a self-limited version of the influenza virus. It induces an immune response against the flu. The vaccine will be built by FluGen’s lab that inserts gene sequences from SARS-CoV-2, the novel coronavirus that causes the disease COVID-19 into M2SR so that the novel vaccine will also induce immunity against the coronavirus.
Important takeaways for all competitive exams:
India's campaign at the Asian Games 2026 kick-off in Aichi-Nagoya in Japan, on the first…
Weekly Current Affairs One-Liners Current Affairs 2026 plays a very important role in competitive examinations…
Tamil Nadu has the highest number of registered GI-tagged textile and handloom items compared to…
Flight Lieutenant Alfred Tyrone Cooke, a highly decorated veteran of Indian Air Force and a…
The Karnataka state government has made the Tulu as the second additional administrative language of…
Tamil Nadu Chief Minister C Joseph Vijay will inaugurate the state's scheme of providing gold…